Meridia Related Clinical Trials
Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes [Completed]
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives [Completed]
Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects [Terminated]
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population [Completed]
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder [Completed]
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. [Completed]
Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS [Completed]
Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates [Active, not recruiting]
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects [Completed]
Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity [Completed]
Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women [Not yet recruiting]
Treatment of Binge Eating in Obese Patients in Primary Care [Recruiting]
A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients. [Active, not recruiting]
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects. [Active, not recruiting]
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects [Active, not recruiting]
Adolescent Weight Management Study [Completed]
Efficacy of MK0557 in Combination With Sibutramine or Orlistat [Completed]
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Completed]
A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects [Completed]
A Comparative Study of KES524 in Patients With Obesity Disease [Completed]
LOSS- Louisiana Obese Subjects Study [Active, not recruiting]
Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity [Recruiting]
Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss [Completed]
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Completed]
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer [Completed]
|
